## ROL: Rollins, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 1.6% below STRENGTH zone (3.0-6.0%); PEG 3.94 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($58.79)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bearish (Bullish: 0, Bearish: 0)

**1. Rollins Inc. stock underperforms Tuesday when compared to competitors**
- Source: MSN | 20251220T100844 | Somewhat-Bearish | Relevance: 100%
- Rollins Inc. (RSI) stock experienced a decline on Tuesday while its competitors saw gains. The company's shares fell by $0.15 to $43.91, underperforming against the S&P 500's positive movement. Despite the daily dip, the stock remains above its 52-week low.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $72 | $58 | +24% |
| 2025-12-05 | Barclays | $72 | $60 | +20% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | up | Overweight |
| 2025-12-05 | Barclays | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 7 ($3296.08M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 7.6% (+4.2%)
- Blackrock Inc.: 6.0% (+1.2%)
- State Street Corpora: 2.5% (+1.4%)
- Kayne Anderson Rudni: 2.0% (-2.8%)
- Geode Capital Manage: 2.0% (+1.7%)

### Key Risks

1. Heavy insider selling: $3296M sold (7 transactions in 90 days).
2. Valuation stretched: PEG 3.9x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.94 signals overvaluation risk, limited margin of safety. Forward P/E 47.8x stretched relative to 12% growth. Quality metrics strong (ROE 36%, ROA 15%). Analyst sentiment positive (2 raises, avg +22%). Insider selling cluster ($3296.1M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $29.4B |
| Beta | 0.79 |
| 52W Range | $45.34 - $61.84 |
| Short Interest | 3.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.94 |
| Forward P/E | 47.8 |
| Current P/E | 53.6 |
| YoY Growth | 12.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 improving modestly (+0.9% over 5 days). Below STRENGTH zone by 1.4pp (needs >3.0% for momentum thesis). MRS_5 at 0.1% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 59. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.57% (CS: 76) | Neutral |
| RSI_14 | 58.9 | Neutral |
| MACD Histogram | -0.03 | Bearish |
| vs SMA20 | 1.013x | Above |
| vs SMA50 | 1.042x | Above |
| vs SMA200 | 1.077x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $61.13
- **Stop Loss:** $58.79 (3.8% risk)
- **Target:** $63.47 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 384
- **Position Value:** $23,473.92
- **Portfolio %:** 23.47%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-18 (Est: $0.27)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.33 | $0.35 | +6.3% |
| 2025Q2 | $0.30 | $0.30 | -0.7% |
| 2025Q1 | $0.22 | $0.22 | +1.3% |
| 2024Q4 | $0.23 | $0.23 | -0.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*